Luxembourg Recalls Supplement 4 for Excessive Caffeine Content

On June 29, 2026, the Food Safety portal of Luxembourg published the recall of Supplement 4, from commercial brand 2 Europe, for presenting excessively high caffeine content compared to the regulatory limits applicable to this type of product. Authorities recommended consumers not to consume the product from affected batches.

Supplements with high doses of concentrated caffeine—common in the fat-burning and sports performance enhancer category—represent a risk whose nature is fundamentally different from microbiological contamination: it is a dose-dependent risk, in which the exact amount of the active compound determines the difference between a tolerable stimulating effect and caffeine intoxication, capable of causing tachycardia, arrhythmias, severe anxiety, or, in extreme cases, serious cardiovascular complications, particularly in people with pre-existing cardiac conditions or in combination with other stimulants.

For TAAG, this recall confirms that the category of food supplements and nutraceuticals demands a dosage control of active ingredients equally rigorous as microbiological control of a conventional food, though of a completely different nature: while microbiological risk is managed through the absence or presence of a pathogen, the risk of a stimulant such as caffeine is managed through the quantitative precision of the formulated dose, a type of control that belongs to chemical-analytical analysis and not to molecular detection of pathogens.